Founders Capital Management (Connecticut)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.74M | Sell |
22,823
-70
| -0.3% | -$15.1K | 0.86% | 24 |
|
|
2026
Q1 | $4.98M | Hold |
22,893
| – | – | 0.82% | 27 |
|
|
2025
Q4 | $5.23M | Buy |
22,893
+32
| +0.1% | +$7.29K | 0.78% | 26 |
|
|
2025
Q3 | $5.29M | Sell |
22,861
-69
| -0.3% | -$14.1K | 0.83% | 25 |
|
|
2025
Q2 | $4.26M | Hold |
22,930
| – | – | 0.72% | 26 |
|
|
2025
Q1 | $4.8M | Sell |
22,930
-87
| -0.4% | -$16.9K | 0.88% | 26 |
|
|
2024
Q4 | $4.09M | Sell |
23,017
-377
| -2% | -$69.3K | 0.72% | 26 |
|
|
2024
Q3 | $4.62M | Sell |
23,394
-332
| -1% | -$62K | 0.8% | 28 |
|
|
2024
Q2 | $4.07M | Hold |
23,726
| – | – | 0.73% | 27 |
|
|
2024
Q1 | $4.32M | Buy |
23,726
+800
| +3% | +$138K | 0.8% | 27 |
|
|
2023
Q4 | $3.55M | Hold |
22,926
| – | – | 0.73% | 28 |
|
|
2023
Q3 | $3.42M | Buy |
22,926
+70
| +0.3% | +$10.3K | 0.78% | 28 |
|
|
2023
Q2 | $3.08M | Hold |
22,856
| – | – | 0.69% | 31 |
|
|
2023
Q1 | $3.64M | Hold |
22,856
| – | – | 0.91% | 25 |
|
|
2022
Q4 | $3.69M | Hold |
22,856
| – | – | 0.99% | 25 |
|
|
2022
Q3 | $3.07M | Hold |
22,856
| – | – | 0.86% | 26 |
|
|
2022
Q2 | $3.5M | Hold |
22,856
| – | – | 0.9% | 24 |
|
|
2022
Q1 | $3.71M | Hold |
22,856
| – | – | 0.8% | 27 |
|
|
2021
Q4 | $3.1M | Sell |
22,856
-260
| -1% | -$30.7K | 0.67% | 31 |
|
|
2021
Q3 | $2.49M | Buy |
23,116
+415
| +2% | +$47.4K | 0.63% | 31 |
|
|
2021
Q2 | $2.56M | Buy |
22,701
+260
| +1% | +$29.3K | 0.62% | 31 |
|
|
2021
Q1 | $2.43M | Hold |
22,441
| – | – | 0.61% | 30 |
|
|
2020
Q4 | $2.4M | Hold |
22,441
| – | – | 0.69% | 31 |
|
|
2020
Q3 | $1.97M | Sell |
22,441
-120
| -0.5% | -$11.3K | 0.62% | 35 |
|
|
2020
Q2 | $2.21M | Hold |
22,561
| – | – | 0.76% | 29 |
|
|
2020
Q1 | $1.72M | Sell |
22,561
-1,044
| -4% | -$88.9K | 0.68% | 32 |
|
|
2019
Q4 | $2.09M | Hold |
23,605
| – | – | 0.69% | 30 |
|
|
2019
Q3 | $1.76M | Hold |
23,605
| – | – | 0.63% | 30 |
|
|
2019
Q2 | $1.72M | Buy |
23,605
+527
| +2% | +$41.4K | 0.61% | 30 |
|
|
2019
Q1 | $1.86M | Sell |
23,078
-105
| -0.5% | -$8.59K | 0.68% | 30 |
|
|
2018
Q4 | $2.14M | Sell |
23,183
-2,244
| -9% | -$197K | 0.92% | 26 |
|
|
2018
Q3 | $2.4M | Buy |
25,427
+400
| +2% | +$37.9K | 0.98% | 26 |
|
|
2018
Q2 | $2.32M | Sell |
25,027
-475
| -2% | -$46.4K | 1.06% | 24 |
|
|
2018
Q1 | $2.33M | Sell |
25,502
-8,258
| -24% | -$907K | 1.07% | 26 |
|
|
2017
Q4 | $3.27M | Sell |
33,760
-498
| -1% | -$46.9K | 1.45% | 23 |
|
|
2017
Q3 | $3.04M | Sell |
34,258
-179
| -0.5% | -$13.6K | 1.45% | 23 |
|
|
2017
Q2 | $2.5M | Hold |
34,437
| – | – | 1.25% | 24 |
|
|
2017
Q1 | $2.24M | Buy |
34,437
+120
| +0.3% | +$7.54K | 1.15% | 24 |
|
|
2016
Q4 | $2.15M | Hold |
34,317
| – | – | 1.16% | 24 |
|
|
2016
Q3 | $2.16M | Hold |
34,317
| – | – | 1.21% | 24 |
|
|
2016
Q2 | $2.13M | Sell |
34,317
-210
| -0.6% | -$12.8K | 1.2% | 26 |
|
|
2016
Q1 | $1.97M | Hold |
34,527
| – | – | 1.15% | 26 |
|
|
2015
Q4 | $2.04M | Sell |
34,527
-6,987
| -17% | -$402K | 1.23% | 26 |
|
|
2015
Q3 | $2.26M | Buy |
41,514
+279
| +0.7% | +$18.2K | 1.46% | 22 |
|
|
2015
Q2 | $2.77M | Hold |
41,235
| – | – | 1.66% | 21 |
|
|
2015
Q1 | $2.41M | Buy |
41,235
+1,785
| +5% | +$108K | 1.44% | 21 |
|
|
2014
Q4 | $2.58M | Buy |
39,450
+802
| +2% | +$50.6K | 1.58% | 22 |
|
|
2014
Q3 | $2.23M | Buy |
38,648
+1,120
| +3% | +$62.2K | 1.43% | 22 |
|
|
2014
Q2 | $2.12M | Buy |
37,528
+450
| +1% | +$23.6K | 1.4% | 22 |
|
|
2014
Q1 | $1.91M | Buy |
37,078
+1,618
| +5% | +$81.8K | 1.53% | 22 |
|
|
2013
Q4 | $1.87M | Buy |
+35,460
| New | +$1.74M | 1.58% | 22 |
|
Other funds holding ABBV
Founders Capital Management (Connecticut)'s ABBV Position: Q2 2026 in Review
Founders Capital Management (Connecticut) reduced its AbbVie (ABBV) stake by 0.31% in Q2 2026, selling an estimated $15.1K and leaving 22,823 shares worth $5.74M. The position accounts for 0.86% of the portfolio, ranked #24.
Founders Capital Management (Connecticut) first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Founders Capital Management (Connecticut) held 22,823 shares of AbbVie worth $5.74M as of Q2 2026.
- Founders Capital Management (Connecticut) sold 70 AbbVie shares in Q2 2026, an estimated $15.1K.
- AbbVie made up 0.86% of Founders Capital Management (Connecticut)'s portfolio in Q2 2026, its #24 holding.
- Founders Capital Management (Connecticut) first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Founders Capital Management (Connecticut)'s 13F filing for Q2 2026, filed 20 Jul 2026.